Rice Hall James & Associates LLC Decreases Position in Mesa Laboratories, Inc. $MLAB

Rice Hall James & Associates LLC cut its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 32.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 17,145 shares of the medical instruments supplier’s stock after selling 8,201 shares during the period. Rice Hall James & Associates LLC’s holdings in Mesa Laboratories were worth $1,149,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of MLAB. CWM LLC increased its holdings in shares of Mesa Laboratories by 48.9% in the third quarter. CWM LLC now owns 597 shares of the medical instruments supplier’s stock worth $40,000 after buying an additional 196 shares during the period. Farther Finance Advisors LLC grew its position in Mesa Laboratories by 17,733.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 535 shares of the medical instruments supplier’s stock worth $36,000 after acquiring an additional 532 shares during the last quarter. Texas Permanent School Fund Corp increased its stake in Mesa Laboratories by 37.6% in the 2nd quarter. Texas Permanent School Fund Corp now owns 3,301 shares of the medical instruments supplier’s stock worth $311,000 after purchasing an additional 902 shares during the period. Public Sector Pension Investment Board increased its stake in Mesa Laboratories by 7.4% in the 2nd quarter. Public Sector Pension Investment Board now owns 18,528 shares of the medical instruments supplier’s stock worth $1,746,000 after purchasing an additional 1,272 shares during the period. Finally, Tower Research Capital LLC TRC lifted its position in Mesa Laboratories by 432.9% in the second quarter. Tower Research Capital LLC TRC now owns 842 shares of the medical instruments supplier’s stock valued at $79,000 after purchasing an additional 684 shares during the last quarter. 90.60% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on MLAB. Wall Street Zen upgraded shares of Mesa Laboratories from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. Weiss Ratings reissued a “sell (d)” rating on shares of Mesa Laboratories in a research report on Wednesday, October 8th. Wells Fargo & Company raised their price target on shares of Mesa Laboratories from $75.00 to $83.00 and gave the stock an “equal weight” rating in a report on Monday, December 15th. Finally, Zacks Research raised shares of Mesa Laboratories to a “strong sell” rating in a research note on Thursday, December 11th. One analyst has rated the stock with a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Sell” and an average price target of $83.00.

Mesa Laboratories Stock Performance

Shares of MLAB stock opened at $80.47 on Friday. The firm has a market capitalization of $444.19 million, a price-to-earnings ratio of -251.47 and a beta of 0.90. The stock has a fifty day moving average of $77.38 and a 200 day moving average of $76.39. Mesa Laboratories, Inc. has a 52 week low of $55.45 and a 52 week high of $155.12. The company has a quick ratio of 1.44, a current ratio of 2.02 and a debt-to-equity ratio of 0.95.

Mesa Laboratories Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, December 15th. Stockholders of record on Friday, November 28th were given a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend was Friday, November 28th. Mesa Laboratories’s dividend payout ratio (DPR) is currently -200.00%.

About Mesa Laboratories

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.